Tags

Type your tag names separated by a space and hit enter

Epidemiology of lyme borreliosis.
Curr Probl Dermatol. 2009; 37:31-50.CP

Abstract

Lyme borreliosis (LB) is the most frequent ixodid tick-borne human disease in the world, with an estimated 85,500 patients annually (underlying data presented in this review: Europe 65,500, North America 16,500, Asia 3,500, North Africa 10; approximate figures). This chapter summarizes the up-to-date knowledge about facts and factors important in the epidemiology of LB all over the world. Individual sections briefly describe geographic (latitudinal and altitudinal) distribution and incidence rates of LB in individual countries; seasonal distribution of the disease; effects of patients' age, sex, and profession; comparison of urban versus rural settings; weather-related effects on LB incidence; risk factors for LB acquisition by humans; and risk assessment. This chapter finishes by recommending a more thorough epidemiological surveillance for LB, including morbidity notification in some additional countries where it has not yet been fully implemented.

Authors

No affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

19367096

Citation

Hubálek, Zdenek. "Epidemiology of Lyme Borreliosis." Current Problems in Dermatology, vol. 37, 2009, pp. 31-50.
Hubálek Z. Epidemiology of lyme borreliosis. Curr Probl Dermatol. 2009;37:31-50.
Hubálek, Z. (2009). Epidemiology of lyme borreliosis. Current Problems in Dermatology, 37, 31-50. https://doi.org/10.1159/000213069
Hubálek Z. Epidemiology of Lyme Borreliosis. Curr Probl Dermatol. 2009;37:31-50. PubMed PMID: 19367096.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Epidemiology of lyme borreliosis. A1 - Hubálek,Zdenek, Y1 - 2009/04/08/ PY - 2009/4/16/entrez PY - 2009/4/16/pubmed PY - 2009/7/3/medline SP - 31 EP - 50 JF - Current problems in dermatology JO - Curr. Probl. Dermatol. VL - 37 N2 - Lyme borreliosis (LB) is the most frequent ixodid tick-borne human disease in the world, with an estimated 85,500 patients annually (underlying data presented in this review: Europe 65,500, North America 16,500, Asia 3,500, North Africa 10; approximate figures). This chapter summarizes the up-to-date knowledge about facts and factors important in the epidemiology of LB all over the world. Individual sections briefly describe geographic (latitudinal and altitudinal) distribution and incidence rates of LB in individual countries; seasonal distribution of the disease; effects of patients' age, sex, and profession; comparison of urban versus rural settings; weather-related effects on LB incidence; risk factors for LB acquisition by humans; and risk assessment. This chapter finishes by recommending a more thorough epidemiological surveillance for LB, including morbidity notification in some additional countries where it has not yet been fully implemented. SN - 1421-5721 UR - https://www.unboundmedicine.com/medline/citation/19367096/full_citation L2 - https://www.karger.com?DOI=10.1159/000213069 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.